Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Olopatadine N-Oxide Hydrochloride

Olopatadine N-Oxide Hydrochloride is listed in the pharmaceutical impurity collection. Its represented structure has formula C21H24ClNO4 and a calculated molecular weight of 389.88 g/mol.

2D chemical structure

N + O - O O O H H C l ( Z )

Chemical identity

Catalog name
Olopatadine N-Oxide Hydrochloride
Common name
Olopatadine N-Oxide Hydrochloride
Chemical name
(3Z)-3-[2-(carboxymethyl)-6H-benzo[c][1]benzoxepin-11-ylidene]-N,N-dimethylpropan-1-amine oxide;hydrochloride
CAS
Not available
SMILES
C[N+](C)([O-])CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl
InChI
InChI=1S/C21H23NO4.ClH/c1-22(2,25)11-5-8-18-17-7-4-3-6-16(17)14-26-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;
InChIKey
PTVMLDSNGXSNDN-NOILCQHBSA-N
Associated API
Olopatadine Hydrochloride

Record ID: A90c1355fd04e

Computed properties

C21H24ClNO4 Molecular formula
389.879 g/molMolecular weight
389.1394 DaMonoisotopic exact mass
69.59 ŲTopological polar surface area
4.0239 Calculated LogP (Wildman–Crippen)
107.8422 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 2 disconnected components. Calculations retain all represented components.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight389.87967.17
Calculated LogP (Wildman–Crippen)4.023978.78
Topological polar surface area69.5949.50
Hydrogen-bond acceptors333.13
Hydrogen-bond donors138.08
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC21H24ClNO4dimensionless
Molecular weight389.879g/mol
Monoisotopic exact mass389.1394Da
Topological polar surface area69.59Ų
Calculated LogP (Wildman–Crippen)4.0239dimensionless
Molar refractivity (Wildman–Crippen)107.8422cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors1count
Rotatable bonds (strict)5count
Heavy atoms27count
Heteroatoms6count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2857fraction
Formal charge0e
Disconnected components2count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area165.018Ų
Valence electrons144count
Radical electrons0count
Bertz complexity855.5004index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Olopatadine N-Oxide Hydrochloride

Qualification and safety assessment of Olopatadine N-Oxide Hydrochloride

Explore toxicological qualification of Olopatadine N-Oxide Hydrochloride and ICH M7 mutagenic impurity assessment of Olopatadine N-Oxide Hydrochloride for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Olopatadine N-Oxide Hydrochloride and acceptable intake and limit justification for Olopatadine N-Oxide Hydrochloride. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Olopatadine N-Oxide Hydrochloride

Explore Altox services and software through the Altox Pharma-Hub.